Early Detection Research Network

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.

No abstract available.

Bailey JM, Bunt SK, Grandgenett PM, Hollingsworth MA, Mohr AM

22864396

Cancer Immunol. Immunother., 2013, 62 (2)